This is the authors' abstract. We don't add key points for this paper.
The first enantioselective synthesis of ( S )-meptazinol in 14 steps from commercially available ethyl 4-oxo-3,4-dihydropyridine-1(2 H )-carboxylate, being widely used in racemic form for pain treatment, and, en route, the formal synthesis of two anti-Alzheimer’s agents are reported. A novel ring expansion of 2-azabicyclo[4.1.0]heptanes, readily available via the stereoselective cyclopropanation of 1,2,3,4-tetrahydropyridine-4-ols, provides an effective entry to 3,3-disubstituted azepanes that represent the core for a variety of approved drugs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Babl et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: